Holen Sie sich die Stockscreener-App
1.94
8.49%
-0.18
Handel nachbörslich:
1.99
0.05
+2.58%
Schlusskurs vom Vortag:
$2.12
Offen:
$2
24-Stunden-Volumen:
5.44M
Relative Volume:
0.68
Marktkapitalisierung:
$17.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.07M
KGV:
-0.1387
EPS:
-13.99
Netto-Cashflow:
$-12.56M
1W Leistung:
+9.60%
1M Leistung:
+110.48%
6M Leistung:
+156.75%
1J Leistung:
-37.42%
1-Tages-Spanne:
$1.92
$2.115
1-Wochen-Bereich:
$1.61
$2.14
52-Wochen-Spanne:
$0.53
$3.30
Palisade Bio Inc Stock (PALI) Company Profile
Firmenname
Palisade Bio Inc
Sektor
Branche
Telefon
(858) 704-4900
Adresse
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Vergleichen Sie PALI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.94 | 282.39M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.89 | 106.97B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.04 | 68.62B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.56 | 63.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
820.36 | 50.61B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.22 | 35.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Palisade Bio Inc Aktie (PALI) Neueste Nachrichten
Using data filters to optimize entry into Palisade Bio Inc.Gap Down & Comprehensive Market Scan Reports - newser.com
How to track smart money flows in Palisade Bio Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
Will Palisade Bio Inc. stock benefit from AI adoptionWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Is Palisade Bio Inc. stock trading near support levelsJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Should I hold or sell Palisade Bio Inc. stock in 2025Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Can volume confirm reversal in Palisade Bio Inc.Volume Spike & Reliable Price Action Trade Plans - newser.com
Palisade Bio’s Unexpected Surge: Analyzing Recent Developments - StocksToTrade
Palisade Bio Inc. recovery potential after sell offJuly 2025 Sector Moves & Real-Time Chart Pattern Alerts - newser.com
Palisade Bio appoints Sharon Skare as VP of global clinical operations - Investing.com Australia
Palisade Bio Inc. stock momentum explainedTrade Analysis Report & Weekly Momentum Picks - newser.com
Forecasting Palisade Bio Inc. price range with options dataJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Palisade Bio Inc Stock Analysis and ForecastTrading Volume Surges & Access High Yield Alerts - earlytimes.in
Will Palisade Bio Inc. stock maintain momentum in 2025July 2025 Intraday Action & Community Consensus Trade Signals - Fundação Cultural do Pará
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations - The Manila Times
Palisade Bio (NASDAQ: PALI) appoints Sharon Skare; IND planned H1 2026 for PALI-2108 - Stock Titan
What sentiment indicators say about Palisade Bio Inc. stockRecession Risk & Precise Buy Zone Tips - newser.com
Automated trading signals detected on Palisade Bio Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
Is Palisade Bio Inc. stock attractive for retirement portfoliosTake Profit & Safe Capital Growth Trade Ideas - newser.com
What MACD and RSI say about Palisade Bio Inc.Weekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Is Palisade Bio Inc. stock vulnerable to regulatory risks2025 Retail Activity & Stock Portfolio Risk Management - Fundação Cultural do Pará
Breakout Watch: What sentiment indicators say about Palisade Bio Inc. stockWeekly Earnings Recap & Free Accurate Trade Setup Notifications - Fundação Cultural do Pará
Why Palisade Bio Inc. (7NS0) stock could outperform next yearQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
Finanzdaten der Palisade Bio Inc-Aktie (PALI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):